02–03 December 2021 • virtual
02–03 December 2021 • virtual
1:00–1:10 pm | Welcome and Introduction Jürgen Ruland | |
1:10–2:40 pm Session Chairs | Session 1 – Immune Metabolism in Cancer Julia Jellusova (School of Medicine, Technical University of Munich/DE), Matthias Heikenwälder (German Cancer Research Center, Division of Chronic Inflammation and Cancer/DE) | |
1:10–1:30 pm | Friend or foe: lipid metabolism in tumor-associated macrophages Ping-Chih Ho (University of Lausanne - Ludwig Institute for Cancer Research/CH) | |
1:40–2:00 pm | Spatial single-cell metabolomics reveals metabolic cell states Theodore Alexandrov (European Molecular Biology Laboratory (EMBL)/DE) | |
2:10–2:30 pm | Environmental impact on T cell metabolism Russel Jones (Van Andel Institute/US) | |
3:00–4:30 pm Session Chairs | Session 2 – Immune Signals and Targets in Lymphoma Maike Buchner (School of Medicine, Technical University of Munich/DE), Julia Hauer (School of Medicine, Technical University of Munich/DE) | |
3:00–3:20 pm | Mechanisms of transformation in Peripheral t-cell Lymphomas Teresa Palomero (Columbia University/US) | |
3:30–3:50 pm | Biomarkers of response and resistance to CD47-SIRPa immunotherapy in T-cell lymphomas Salvia Jain (Massachusetts General Hospital Cancer Center/US) | |
4:00–4:20 pm | Epigenetic mechanisms driving transformation of the immune system Ari M. Melnick (Weill Cornell Medicine/US) | |
4:50–6:45 pm Session Chairs | Session 3 – Immune Recognition of Cancer Cells Barbara Schraml (Ludwig-Maximilians-Universität München/DE), Simon Heidegger (School of Medicine, Technical University of Munich/DE) | |
4:50–5:10 pm | How Immune Cells Recognize and Target Tumor Cells Timothy Chan (Cleveland Clinic/US) | |
5:20–5:40 pm | Exploring principles of T-cell therapy in melanoma Michael Hölzel (University Hospital Bonn/DE) | |
5:50–6:30 pm | Keynote Lecture Necrophagia, DaNGeRous indigestion and immunity to cancer Caetano Reis e Sousa (The Francis Crick Institute/GB) |
1:00–2:30 pm Session Chairs | Session 4 – Innate Immunity and Inflammation in Cancer Marc Schmidt-Supprian (School of Medicine, Technical University of Munich/DE), Dieter Saur (School of Medicine, Technical University of Munich/DE) | |
1:00–1:20 pm | Trained granulopoiesis in cancer Triantafyllos Chavakis (Technical University of Dresden/DE) | |
1:30–1:50 pm | Cell Plasticity in Colorectal Carcinogenesis Florian Greten (Georg-Speyer-Haus/DE) | |
2:00–2:20 pm | Sensing DNA as a danger signal through the cGAS-STING pathway Andrea Ablasser (Ecole polytechnique fédérale de Lausanne/CH) | |
2:50–4:15 pm Session Chairs | Session 5 – Immune Recognition of Cancer Cells Oliver Weigert (Laboratory for Experimental Leukemia and Lymphoma Research (ELLF)/DE), Hendrik Poeck (University Hospital Regensburg/DE) | |
2:50–3:10 pm | Decoding and Recoding the Opposing Roles of Interferon and Pattern Recognition Receptor Signaling in Cancer Immunotherapy Andy J. Minn (Abramson Family Cancer Research Institute/US) | |
3:20–4:00 pm | Keynote Lecture Cell types, states and programs underlying human immune response Nir Hacohen (Broad Institute of MIT and Harvard/US) | |
4:15 pm | Closing Remarks Florian Bassermann |